TickerFactsScreenerDevelopers

Crinetics Pharmaceuticals, Inc. (CRNX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2017: $14.19M2018: $44.97M2019: $40.33M2020: $93.09M2021: $200.69M2022: $32.67M2023: $54.90M2024: $264.55M2025: $101.54M$101.54M
2017Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$101.54M-61.6%
2024$264.55M+381.9%
2023$54.90M+68.0%
2022$32.67M-83.7%
2021$200.69M+115.6%
2020$93.09M+130.8%
2019$40.33M-10.3%
2018$44.97M+216.9%
2017$14.19M—